Ken Roger Rosendal

Spermatech AS develops a non-hormonal male contraception pill. It operates as an early drug development company that identifies small molecules which can be developed into non-hormonal male contraceptives. The firm develops a test set-up using living human sperm cells. The company was founded by Eirik Næss-Ulseth and Bjorn Steen Skalhegg in 2002 and is headquartered in Oslo, Norway.

Spermatech AS develops a non-hormonal male contraception pill. It operates as an early drug development company that identifies small molecules which can be developed into non-hormonal male contraceptives. The firm develops a test set-up using living human sperm cells. The company was founded by Eirik Næss-Ulseth and Bjorn Steen Skalhegg in 2002 and is headquartered in Oslo, Norway.

Spermatech AS develops a non-hormonal male contraception pill. It operates as an early drug development company that identifies small molecules which can be developed into non-hormonal male contraceptives. The firm develops a test set-up using living human sperm cells. The company was founded by Eirik Næss-Ulseth and Bjorn Steen Skalhegg in 2002 and is headquartered in Oslo, Norway.

Spermatech AS develops a non-hormonal male contraception pill. It operates as an early drug development company that identifies small molecules which can be developed into non-hormonal male contraceptives. The firm develops a test set-up using living human sperm cells. The company was founded by Eirik Næss-Ulseth and Bjorn Steen Skalhegg in 2002 and is headquartered in Oslo, Norway.

Spermatech AS develops a non-hormonal male contraception pill. It operates as an early drug development company that identifies small molecules which can be developed into non-hormonal male contraceptives. The firm develops a test set-up using living human sperm cells. The company was founded by Eirik Næss-Ulseth and Bjorn Steen Skalhegg in 2002 and is headquartered in Oslo, Norway.